Terlipressin Acetate

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

特利加压素是一种高选择性加压素 V1 受体激动剂，可抑制缺氧和葡萄糖剥夺/再氧合 (OGD/R) 引起的肠上皮细胞损伤 (IEC-6)。

Terlipressin, a highly selective vasopressin V1 receptor agonist, on oxygen and glucose deprivation/re-oxygenation (OGD/R)-induced damage in intestinal epithelial cells (IEC-6).Terlipressin acetate exerts anti-inflammatory and anti-oxidative effects. Terlipressin acetate has the potential for hepatorenal syndrome and norepinephrine-resistant septic shock research.

Cell Proliferation Assay Cell Line:IEC-6 cells induced by oxygen and glucose deprivation/re-oxygenation (OGD/R)Concentration:25 nM Incubation Time:24 hours, 48 hours, 72 hours Result:Significantly increased the proliferation of IEC-6 cells.

——

Terlipressin diacetate anhydrous | Terlipressin acetate anhydrous

GPCR/G Protein

Vasopressin Receptor

vasopressin V1

——

——

1884420-36-3

1347.5

C56H82N16O19S2

>98% (HPLC)

DMSO:95mg/mL (70.50mM)

O=C([C@H](CSSC[C@@H](C(N[C@H](C1=O)CC2=CC=C(O)C=C2)=O)NC(CNC(CNC(CN)=O)=O)=O)NC([C@@H](NC([C@@H](NC([C@](N1)([H])CC3=CC=CC=C3)=O)CCC(N)=O)=O)CC(N)=O)=O)N(CCC4)[C@@H]4C(N[C@@H](CCCCN)C(NCC(N)=O)=O)=O.CC(O)=O.CC(O)=O

——

(-20℃)

With Ice Pack

≥ 2 years